瑞士型权利要求

为了保护物质医药用途，欧洲专利局创造性地提出了瑞士型权利要求。

In order to protect the pharmaceutical usage of a substance , EPO provides at first the Swiss-type claim .

最近几年，欧洲专利局对于瑞士型权利要求的认识有了非常大的变化，并且已经在去年否定了瑞士型权利要求仅局限于药物制造过程的传统观点。

Recently , the understanding of EPO for the Swiss-type claim is greatly changed , and EPO confirm that the Swiss-type claim is not limited to the process for producing a medicine .

在第三章中，本文论述了瑞士型权利要求在欧洲的新动向，包括以治疗对象、给药剂量和给药方案为区别技术特征的瑞士型权利要求。

In the third chapter , this thesis discusses the new development of the Swiss-type claim in Europe , including the Swiss-type claim having a distinguishing technical feature based on administrating object , administration dosage or administration scheme .

为了保护这种医药的新用途发明，瑞士人提出了医药用途权利要求，即瑞士型权利要求。

In order to protect the new uses invention of medicines , a Swiss has claimed the right for medical uses , which is the " Swiss-type-claim " .